We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Trial Drug Effective Against Hospital SA Infections
NIH Trial Drug Effective Against Hospital SA Infections
Destiny Pharma reported positive safety and efficacy results from an NIH-supported clinical trial of exeporfinium chloride, for the prevention of post-surgical staphylococcal infections.